The association of HLA-G polymorphism with oral and genital HPV infection in men.
Genital
HLA-G
HPV
Human papillomavirus
Men
Oral
Journal
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
20
04
2021
accepted:
04
10
2021
pubmed:
27
10
2021
medline:
1
2
2022
entrez:
26
10
2021
Statut:
ppublish
Résumé
The host genetic factors that influence the natural history of human papillomavirus (HPV) infection in men are not well known. Our aim was to evaluate the role of human leukocyte antigen (HLA)-G polymorphism in oral and genital HPV infection in men. Altogether, 130 men from the Finnish Family HPV Study, with a 6-year follow-up, were included in the analyses. HLA-G alleles were tested by direct sequencing. Oral, urethral, and semen samples were collected and analyzed for 24 different HPV genotypes. Unconditional logistic regression was used to determine associations between HLA-G alleles and genotypes with HPV infection and its outcomes. Overall, eight different HLA-G alleles were identified with 15 different HLA-G genotype combinations. The most common HLA-G allele among the men was G*01:01:01 (86.2%, n = 112) followed by G*01:01:02 (36.2%, n = 47). Allele G*01:01:02 showed to be protective against any- and high-risk (HR) oral HPV (OR range of 0.20-0.24, 95% CI range of 0.06-0.85). Men having allele G*01:01:01 showed a reduced risk for incident (OR 0.30, 95% CI 0.11-0.84) and persistent (OR 0.24, 95% CI 0.08-0.69) oral infections. Allele G*01:01:03 was associated with increased risk for urethral HR-HPV infections (OR 4.94, 95% CI 1.34-18.27). Among self-reported demographic data, genotype G*01:01:01/01:01:03 was associated with an increased risk for oral warts (OR 8.00, 95% CI 1.23-51.89) and allele G*01:03:01 increased the risk of pollen and/or animal allergy (OR 13.59, 95% CI 1.57-117.25). To conclude, HLA-G polymorphism in men largely impacts the outcome of an oral HPV infection and seems to associate with self-reported allergies.
Identifiants
pubmed: 34697671
doi: 10.1007/s10096-021-04362-8
pii: 10.1007/s10096-021-04362-8
pmc: PMC8770419
doi:
Substances chimiques
HLA-G Antigens
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
219-226Informations de copyright
© 2021. The Author(s).
Références
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492
doi: 10.3322/caac.21492
pubmed: 30207593
de Martel C, Plummer M, Vignat J, Franceschi S (2017) Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer 141:664–670. https://doi.org/10.1002/ijc.30716
doi: 10.1002/ijc.30716
pubmed: 28369882
pmcid: 5520228
Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR (2006) Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis 194:1044–1057. https://doi.org/10.1086/507432
doi: 10.1086/507432
pubmed: 16991079
Smith JS, Gilbert PA, Melendy A, Rana RK, Pimenta JM (2011) Age-specific prevalence of human papillomavirus infection in males: a global review. J Adolesc Health 48:540–552. https://doi.org/10.1016/j.jadohealth.2011.03.010
doi: 10.1016/j.jadohealth.2011.03.010
pubmed: 21575812
Rodríguez-Álvarez MI, Gómez-Urquiza JL, Husein-El Ahmed H, Albendín-García L, Gómez-Salgado J, Cañadas-De la Fuente GA (2018) Prevalence and risk factors of human papillomavirus in male patients: a systematic review and meta-analysis. Int J Environ Res Public Health 15:2210. https://doi.org/10.3390/ijerph15102210
doi: 10.3390/ijerph15102210
pmcid: 6210641
Lyu Z, Feng X, Li N, Zhao W, Wei L, Chen Y et al (2017) Human papillomavirus in semen and the risk for male infertility: a systematic review and meta-analysis. BMC Infect Dis 17:714. https://doi.org/10.1186/s12879-017-2812-z
doi: 10.1186/s12879-017-2812-z
pubmed: 29121862
pmcid: 5679371
Fainardi E, Castellazzi M, Stignani M, Morandi F, Sana G, Gonzalez R et al (2011) Emerging topics and new perspectives on HLA-G. Cell Mol Life Sci 68:433–451. https://doi.org/10.1007/s00018-010-0584-3
doi: 10.1007/s00018-010-0584-3
pubmed: 21080027
Donadi EA, Castelli EC, Arnaiz-Villena A, Roger M, Rey D, Moreau P (2011) Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci 68:369–395. https://doi.org/10.1007/s00018-010-0580-7
doi: 10.1007/s00018-010-0580-7
pubmed: 21107637
González Ã, Rebmann V, LeMaoult J, Horn PA, Carosella ED, Alegre E (2012) The immunosuppressive molecule HLA-G and its clinical implications. Crit Rev Clin Lab Sci 49:63–84. https://doi.org/10.3109/10408363.2012.677947
doi: 10.3109/10408363.2012.677947
pubmed: 22537084
Morandi F, Rizzo R, Fainardi E, Rouas-Freiss N, Pistoia V (2016) Recent advances in our understanding of HLA-G biology: lessons from a wide spectrum of human diseases. J Immunol Res 2016. https://doi.org/10.1155/2016/4326495
Xu HH, Yan W-H, Lin A (2020) The Role of HLA-G in human papillomavirus infections and cervical carcinogenesis. Front Immunol 11. https://doi.org/10.3389/fimmu.2020.01349
Rintala MA, Grénman SE, Järvenkylä ME, Syrjänen KJ, Syrjänen SM (2005) High-risk types of human papillomavirus (HPV) DNA in oral and genital mucosa of infants during their first 3 years of life: experience from the Finnish HPV Family Study. Clin Infect Dis 41:1728–1733. https://doi.org/10.1086/498114
doi: 10.1086/498114
pubmed: 16288396
Louvanto K, Rintala MA, Syrjänen KJ, Grénman SE, Syrjänen SM (2010) Genotype-specific persistence of genital human papillomavirus (HPV) infections in women followed for 6 years in the Finnish Family HPV Study. J Infect Dis 202:436–444. https://doi.org/10.1086/653826
doi: 10.1086/653826
pubmed: 20557239
Rintala MA, Grénman SE, Pöllänen PP, Suominen JJ, Syrjänen SM (2004) Detection of high-risk HPV DNA in semen and its association with the quality of semen. Int J STD AIDS 15:740–743. https://doi.org/10.1258/0956462042395122
doi: 10.1258/0956462042395122
pubmed: 15537460
Kero K, Rautava J, Syrjänen K, Grenman S, Syrjänen S (2011) Human papillomavirus genotypes in male genitalia and their concordance among pregnant spouses participating in the Finnish Family HPV study. J Sex Med 8:2522–2531. https://doi.org/10.1111/j.1743-6109.2011.02378.x
doi: 10.1111/j.1743-6109.2011.02378.x
pubmed: 21718450
Kero KM, Rautava J, Syrjänen K, Kortekangas-Savolainen O, Grenman S, Syrjänen S (2014) Stable marital relationship protects men from oral and genital HPV infections. Eur J Clin Microbiol Infect Dis 33:1211–1221. https://doi.org/10.1007/s10096-014-2061-7
doi: 10.1007/s10096-014-2061-7
pubmed: 24504632
Kero K, Rautava J, Syrjänen K, Grenman S, Syrjänen S (2012) Oral mucosa as a reservoir of human papillomavirus: point prevalence, genotype distribution, and incident infections among males in a 7-year prospective study. Eur Urol 62:1063–1070. https://doi.org/10.1016/j.eururo.2012.06.045
doi: 10.1016/j.eururo.2012.06.045
pubmed: 22771267
Kero K, Rautava J, Syrjänen K, Willberg J, Grenman S, Syrjänen S (2014) Smoking increases oral HPV persistence among men: 7-year follow-up study. Eur J Clin Microbiol Infect Dis 33:123–133. https://doi.org/10.1007/s10096-013-1938-1
doi: 10.1007/s10096-013-1938-1
pubmed: 24026862
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215. https://doi.org/10.1093/nar/16.3.1215
doi: 10.1093/nar/16.3.1215
pubmed: 3344216
pmcid: 334765
Snijders PJ, van den Brule AJ, Schrijnemakers HF, Snow G, Meijer CJ, Walboomers JM (1990) The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol 71:173–181. https://doi.org/10.1099/0022-1317-71-1-173
doi: 10.1099/0022-1317-71-1-173
pubmed: 2154534
Ferguson R, Ramanakumar AV, Richardson H, Tellier P-P, Coutlée F, Franco E et al (2011) Human leukocyte antigen (HLA)-E and HLA-G polymorphisms in human papillomavirus infection susceptibility and persistence. Hum Immunol 72:337–341. https://doi.org/10.1016/j.humimm.2011.01.010
doi: 10.1016/j.humimm.2011.01.010
pubmed: 21256910
Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A et al (2010) A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res 70:3159–3169. https://doi.org/10.1158/0008-5472.CAN-09-4179
doi: 10.1158/0008-5472.CAN-09-4179
pubmed: 20354192
pmcid: 2855741
Simões RT, Gonçalves MA, Castelli EC, Júnior CM, Bettini JS, Discorde ML et al (2009) HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus. Mod Pathol 22:1075–1082. https://doi.org/10.1038/modpathol.2009.67
doi: 10.1038/modpathol.2009.67
pubmed: 19407850
Metcalfe S, Roger M, Faucher M-C, Coutlée F, Franco EL, Brassard P (2013) The association between human leukocyte antigen (HLA)-G polymorphisms and human papillomavirus (HPV) infection in Inuit women of northern Quebec. Hum Immunol 74:1610–1615. https://doi.org/10.1016/j.humimm.2013.08.279
doi: 10.1016/j.humimm.2013.08.279
pubmed: 23994586
Gimenes F, Teixeira JJ, de Abreu AL, Souza RP, Pereira MW, da Silva VR et al (2014) Human leukocyte antigen (HLA)-G and cervical cancer immunoediting: a candidate molecule for therapeutic intervention and prognostic biomarker? Biochim Biophys Acta 1846:576–589. https://doi.org/10.1016/j.bbcan.2014.10.004
doi: 10.1016/j.bbcan.2014.10.004
pubmed: 25453366
Yang Y-C, Chang T-Y, Chen T-C, Lin W-S, Chang S-C, Lee Y-J (2014) Human leucocyte antigen-G polymorphisms are associated with cervical squamous cell carcinoma risk in Taiwanese women. Eur J Cancer 50:469–474. https://doi.org/10.1016/j.ejca.2013.10.018
doi: 10.1016/j.ejca.2013.10.018
pubmed: 24262586
Xu H-H, Shi W-W, Lin A, Yan W-H (2014) HLA-G 3’ untranslated region polymorphisms influence the susceptibility for human papillomavirus infection. Tissue Antigens 84:216–222. https://doi.org/10.1111/tan.12359
doi: 10.1111/tan.12359
pubmed: 24758208
Xu H-H, Zhang X, Zheng H-H, Han Q-Y, Lin A-F, Yan W-H (2018) Association of HLA-G 3’ UTR polymorphism and expression with the progression of cervical lesions in human papillomavirus 18 infections. Infect Agent Cancer 13:42. https://doi.org/10.1186/s13027-018-0217-2
doi: 10.1186/s13027-018-0217-2
pubmed: 30619504
pmcid: 6311041
Louvanto K, Roger M, Faucher M-C, Syrjänen K, Grenman S, Syrjänen S (2018) HLA-G and vertical mother-to-child transmission of human papillomavirus infection. Hum Immunol 79:471–476. https://doi.org/10.1016/j.humimm.2018.03.002
doi: 10.1016/j.humimm.2018.03.002
pubmed: 29544814
Cordero EA, Veit TD, da Silva MA, Jacques SM, Silla LM, Chies JA (2009) HLA-G polymorphism influences the susceptibility to HCV infection in sickle cell disease patients. Tissue Antigens 74:308–313. https://doi.org/10.1111/j.1399-0039.2009.01331.x
doi: 10.1111/j.1399-0039.2009.01331.x
pubmed: 19775370
Eskandari E, Dahmardeh T, Safdari V, Khosravi S, Pahlevani E (2017) HLA-G gene 14-bp deletion variant protects Iranian subjects against chronic hepatitis B infection. Int J Immunogenet 44:322–327. https://doi.org/10.1111/iji.12337
doi: 10.1111/iji.12337
pubmed: 28929613
Laaribi AB, Zidi I, Hannachi N, Ben Yahia H, Chaouch H, Bortolotti D et al (2015) Association of an HLA-G 14-bp Insertion/Deletion polymorphism with high HBV replication in chronic hepatitis. J Viral Hepat 22:835–841. https://doi.org/10.1111/jvh.12395
doi: 10.1111/jvh.12395
pubmed: 25619305
Larsen MH, Zinyama R, Kallestrup P, Gerstoft J, Gomo E, Thørner LW et al (2013) HLA-G 3′ untranslated region 14-base pair deletion: association with poor survival in an HIV-1-infected Zimbabwean population. J Infect Dis 207:903–906. https://doi.org/10.1093/infdis/jis924
doi: 10.1093/infdis/jis924
pubmed: 23264673
da Silva GK, Vianna P, Veit TD, Crovella S, Catamo E, Cordero EAA et al (2014) Influence of HLA-G polymorphisms in human immunodeficiency virus infection and hepatitis C virus co-infection in Brazilian and Italian individuals. Infect Genet Evol 21:418–423. https://doi.org/10.1016/j.meegid.2013.12.013
doi: 10.1016/j.meegid.2013.12.013
pubmed: 24389119
Zambra FM, Biolchi V, de Cerqueira CC, Brum IS, Castelli EC, Chies JA (2016) Immunogenetics of prostate cancer and benign hyperplasia-the potential use of an HLA-G variant as a tag SNP for prostate cancer risk. HLA 87:79–88. https://doi.org/10.1111/tan.12741
doi: 10.1111/tan.12741
pubmed: 26889902
Alves BM, Prellwitz IM, Siqueira JD, Meyrelles ÂR, Bergmann A, Seuánez HN et al (2015) The effect of human leukocyte antigen G alleles on human papillomavirus infection and persistence in a cohort of HIV-positive pregnant women from Brazil. Infect Genet Evol 34:339–343. https://doi.org/10.1016/j.meegid.2015.06.027
doi: 10.1016/j.meegid.2015.06.027
pubmed: 26134300
Ferguson R, Ramanakumar AV, Koushik A, Coutlée F, Franco E, Roger M (2012) Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix. Int J Cancer 131:E312–E319. https://doi.org/10.1002/ijc.27356
doi: 10.1002/ijc.27356
pubmed: 22095460
Murdaca G, Contini P, Negrini S, Ciprandi G, Puppo F (2016) Immunoregulatory role of HLA-G in allergic diseases. J Immunol Res. https://doi.org/10.1155/2016/6865758
doi: 10.1155/2016/6865758
pubmed: 27413762
pmcid: 4931064
Carosella ED, Rouas-Freiss N, Tronik-Le Roux D, Moreau P, LeMaoult J (2015) HLA-G: an immune checkpoint molecule. Adv Immunol 127:33–144. https://doi.org/10.1016/bs.ai.2015.04.001
doi: 10.1016/bs.ai.2015.04.001
pubmed: 26073983
Contini P, Puppo F, Canonica GW, Murdaca G, Ciprandi G (2016) Allergen-driven HLA-G expression and secretion in peripheral blood mononuclear cells from allergic rhinitis patients. Hum Immunol 77:1172–1178. https://doi.org/10.1016/j.humimm.2016.08.005
doi: 10.1016/j.humimm.2016.08.005
pubmed: 27527921
Catamo E, Zupin L, Freato N, Polesello V, Celsi F, Crocè SL et al (2017) HLA-G regulatory polymorphisms are associated with susceptibility to HCV infection. HLA 89:135–142. https://doi.org/10.1111/tan.12959
doi: 10.1111/tan.12959
pubmed: 28083985